Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous cell-mixed sheet transplantation for refractory venous skin ulcer
jRCTb060190034Completed
- Start
- Mar 2018
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of autologous fibroblast and peripheral blood mononuclear cell mixed sheet in stasis ulcer. Primary endpoint: Presence or absence, frequency, and severity of all adverse events. Started Mar 2018; status: completed.
02
Drugs
autologous fibroblast and peripheral blood mononuclear cell mixed sheet
03
Conditions
stasis ulcer
Beyond the preview
Go deeper on jRCTb060190034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTb060190034.